Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Cardiovascular Imaging Reports
Published in: Current Cardiovascular Imaging Reports 1/2011

01-02-2011

Emerging Approaches for Cardiovascular Stem Cell Imaging

Authors: Dorota A. Kedziorek, Dara L. Kraitchman

Published in: Current Cardiovascular Imaging Reports | Issue 1/2011

Login to get access

Abstract

Stem cell therapies offer potential therapeutic alternatives for coronary artery disease, myocardial infarction, and heart failure. To a lesser extent, stem cell transplantations are used for experimental treatment of congenital heart conditions, atherosclerotic peripheral arterial disease, and other cardiovascular pathologies. The efficacy of stem cell transplants on the aforementioned diseases has been inconsistent, and the specific regenerative mechanisms by which stem cells work are not well understood. Thus, a reliable and efficient method of cell tracking and monitoring would be beneficial. The different imaging strategies and modalities for cell tracking, as well as the latest approaches to cell labeling in this field, are reviewed in the hope that this will foster a better understanding of the best methods to treat cardiovascular diseases with cellular therapeutics.
Literature
1.
Lloyd-Jones D, Adams RJ, Brown TM, et al., Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010, 121(7):948–954.CrossRefPubMed
2.
Quevedo HC, Hatzistergos KE, Oskouei BN, et al., Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 2009, 106(33):14022–7.CrossRefPubMed
3.
Nelson TJ, Martinez-Fernandez A, Yamada S, et al., Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009, 120(5):408–16.CrossRefPubMed
4.
Rosenzweig A, Cardiac cell therapy–mixed results from mixed cells. N Engl J Med 2006, 355(12):1274–7.CrossRefPubMed
5.
Assmus B, Honold J, Schachinger V, et al., Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355(12):1222–32.CrossRefPubMed
6.
• Menasche P, Cardiac cell therapy: Lessons from clinical trials. J Mol Cell Cardiol. 2010, epub 2010/07/06. This is a detailed overview of clinical trials with stem cell therapies for cardiac diseases.
7.
Wu JC, Abraham MR, and Kraitchman DL, Current perspectives on imaging cardiac stem cell therapy. J Nucl Med, 51 Suppl 1:128S–136S.
8.
Frangioni JV and Hajjar RJ, In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 2004, 110(21):3378–83.CrossRefPubMed
9.
Kedziorek DA and Kraitchman DL, Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease. Methods Mol Biol 2010, 660:171–83.CrossRefPubMed
10.
Walczak P, Kedziorek DA, Gilad AA, et al., Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn Reson Med 2007, 58(2):261–9.CrossRefPubMed
11.
Liu J, Cheng EC, Long Jr RC, et al., Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng Part C Methods 2009.
12.
• Chen IY, Greve JM, Gheysens O, et al., Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol Imaging Biol 2009, 11(3):178–87. This preclinical study suggests that bioluminescence is a more accurate technique for transplanted cell survival estimation than MRI of iron oxide–labeled cells. CrossRefPubMed
13.
• Gyongyosi M, Blanco J, Marian T, et al., Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging 2008, 1(2):94–103. This is the first large animal preclinical study with reporter gene imaging using clinical scanners demonstrating potential for clinical translation. CrossRefPubMed
14.
Gilad AA, McMahon MT, Walczak P, et al., Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 2007, 25(2):217–219.CrossRefPubMed
15.
Pawelczyk E and Frank JA, Transferrin receptor expression in iron oxide-labeled mesenchymal stem cells. Radiology 2008, 247(3):913; author reply 914–5.CrossRefPubMed
16.
Bulte JW and Kraitchman DL, Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004, 17(7):484–499.CrossRefPubMed
17.
• Adler ED, Bystrup A, Briley-Saebo KC, et al., In vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardium. JACC Cardiovasc Imaging 2009, 2(9):1114–22. This is an interesting study employing gadolinium-based contrast agent for murine embryonic stem cell–derived tracking of post-intramyocardial transplantation. CrossRefPubMed
18.
Budde MD and Frank JA, Magnetic tagging of therapeutic cells for MRI. J Nucl Med 2009, 50(2):171–4.CrossRefPubMed
19.
Brekke C, Morgan SC, Lowe AS, et al., The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed 2007, 20(2):77–89.CrossRefPubMed
20.
Anderson SA, Lee KK, and Frank JA, Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest Radiol 2006, 41(3):332–8.CrossRefPubMed
21.
Kraitchman DL and Bulte JW, In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods. Arterioscler Thromb Vasc Biol 2009, 29(7):1025–30.CrossRefPubMed
22.
Cunningham CH, Arai T, Yang PC, et al., Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005, 53(5):999–1005.CrossRefPubMed
23.
Mani V, Adler E, Briley-Saebo KC, et al., Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn Reson Med 2008, 60(1):73–81.CrossRefPubMed
24.
Stuber M, Gilson WD, Schär M, et al., Positive contrast visualization of iron oxide-labeled stem cells using inversion recovery with ON-resonant water suppression (IRON). Magn Reson Med 2007, 58:1072–1077.CrossRefPubMed
25.
Dahnke H, Liu W, Herzka D, et al., Susceptibility gradient mapping (SGM): a new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells. Magn Reson Med 2008, 60(3):595–603.CrossRefPubMed
26.
• Zhou R, Idiyatullin D, Moeller S, et al., SWIFT detection of SPIO-labeled stem cells grafted in the myocardium. Magn Reson Med 2010, 63(5):1154–61. This is a report from a study using a novel positive-contrast method to detect murine embryonic stem cells labeled with iron oxide particles and injected into the myocardium. CrossRefPubMed
27.
Frank JA, Miller BR, Arbab AS, et al., Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003, 228(2):480–7.CrossRefPubMed
28.
Kostura L, Kraitchman DL, Mackay AM, et al., Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004, 17(7):513–7.CrossRefPubMed
29.
Kedziorek DA, Muja N, Walczak P, et al., Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med 2010, 63(4):1031–43.CrossRefPubMed
30.
de Silva R, Gutierrez LF, Raval AN, et al., X-Ray Fused with Magnetic Resonance Imaging (XFM) to target endomyocardial injections. Validation in a swine model of myocardial infarction. Circulation 2006, 114(22):2342–2350.CrossRefPubMed
31.
Li Z, Suzuki Y, Huang M, et al., Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 2008, 26(4):864–73.CrossRefPubMed
32.
Ebert SN, Taylor DG, Nguyen HL, et al., Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells 2007, 25(11):2936–44.CrossRefPubMed
33.
Partlow KC, Chen J, Brant JA, et al., 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb J 2007, 21(8):1647–54.CrossRefPubMed
34.
Graham JJ, Foltz WD, Vaags AK, et al., Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI. Am J Physiol Heart Circ Physiol 2010, 299(1):H125–33.CrossRefPubMed
35.
Psaltis PJ, Zannettino AC, Gronthos S, and Worthley SG, Intramyocardial navigation and mapping for stem cell delivery. J Cardiovasc Transl Res 2010, 3(2):135–46.CrossRefPubMed
36.
Jameel MN, Li Q, Mansoor A, et al., Long-term functional improvement and gene expression changes after bone marrow-derived multipotent progenitor cell transplantation in myocardial infarction. Am J Physiol Heart Circ Physiol 2010, 298(5):H1348–56.CrossRefPubMed
37.
• Rodriguez-Porcel M, In vivo imaging and monitoring of transplanted stem cells: clinical applications. Curr Cardiol Rep 2010, 12(1):51–8. This is an excellent review of stem cell therapies for cardiovascular disease imaging. CrossRefPubMed
38.
Terrovitis J, Lautamaki R, Bonios M, et al., Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 2009, 54(17):1619–26.CrossRefPubMed
39.
Higuchi T, Anton M, Saraste A, et al., Reporter gene PET for monitoring survival of transplanted endothelial progenitor cells in the rat heart after pretreatment with VEGF and atorvastatin. J Nucl Med 2009, 50(11):1881–6.CrossRefPubMed
40.
Willmann JK, Paulmurugan R, Rodriguez-Porcel M, et al., Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology 2009, 252(1):117–27.CrossRefPubMed
41.
Terrovitis J, Kwok KF, Lautamaki R, et al., Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J Am Coll Cardiol 2008, 52(20):1652–60.CrossRefPubMed
42.
van der Bogt KE, Sheikh AY, Schrepfer S, et al., Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 2008, 118(14 Suppl):S121–9.CrossRefPubMed
43.
Swijnenburg RJ, Govaert JA, van der Bogt KE, et al., Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction. Circ Cardiovasc Imaging 2010, 3(1):77–85.CrossRefPubMed
44.
Gruber PJ, Li Z, Li H, et al., In vivo imaging of MLC2v-luciferase, a cardiac-specific reporter gene expression in mice. Acad Radiol 2004, 11(9):1022–8.CrossRefPubMed
45.
• Sutton EJ, Henning TD, Pichler BJ, et al., Cell tracking with optical imaging. Eur Radiol 2008, 18(10):2021–32. This is a comprehensive overview of emerging applications for optical imaging techniques for in vivo monitoring of new stem cell–based therapies. CrossRefPubMed
46.
• Ly HQ, Hoshino K, Pomerantseva I, et al., In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction. Eur Heart J 2009, 30(23):2861–8. This remarkable study used quantum dots and fluorescence to track stem cells post-intracoronary delivery.CrossRefPubMed
47.
Rosen AB, Kelly DJ, Schuldt AJ, et al., Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007, 25(8):2128–38.CrossRefPubMed
48.
• Kuliszewski MA, Fujii H, Liao C, et al., Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles. Cardiovasc Res 2009, 83(4):653–62. This is an interesting study employing ultrasound to track the vascular engraftment of endothelial progenitor cells.CrossRefPubMed
49.
Barnett BP, Arepally A, Karmarkar PV, et al., Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med 2007, 13(8):986–91.CrossRefPubMed
50.
• Barnett BP, Kraitchman DL, Lauzon C, et al., Radiopaque alginate microcapsules for X-ray visualization and immunoprotection of cellular therapeutics. Mol Pharm 2006, 3(5):531–8. This is the first X-ray visible stem cell therapy comprised of clinical components in small animals. CrossRefPubMed
Metadata
Title
Emerging Approaches for Cardiovascular Stem Cell Imaging
Authors
Dorota A. Kedziorek
Dara L. Kraitchman
Publication date
01-02-2011
Publisher
Current Science Inc.
Published in
Current Cardiovascular Imaging Reports / Issue 1/2011
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-010-9057-1

Other articles of this Issue 1/2011

Current Cardiovascular Imaging Reports 1/2011 Go to the issue

ReviewPaper

Microparticle-Based Molecular MRI of Atherosclerosis, Thrombosis, and Tissue Ischemia

ReviewPaper

Imaging Myeloperoxidase Activity in Cardiovascular Disease

ReviewPaper

Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation

ReviewPaper

Molecular MRI of Thrombosis

ReviewPaper

Imaging of Oxidation-Specific Epitopes in Atherosclerosis and Macrophage-Rich Vulnerable Plaques

ReviewPaper

Molecular Imaging of Healing After Myocardial Infarction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits